Member Info for 13thmonkey

With fewer side effects the actual cost will be a lot lower even if if the drug prices were the same.

No, I think * **** ******* *** ******* ****

LDA, are you a simpleton?

If you have a personal relationship then perhaps telling him that the Comms don't seem to have improved from down here works be better than putting down the efforts than they have made. I'm sure he'd prefer that than you being negative on a public forum.

Touk doesn't keep up, or even pay attention really, I'm not sure there's any point in pointing out his obvious lack of knowledge.

Ice you can say the same about pharma3 and livedata both add zero.

Life's only comments in recent days has been MTD as if avacta can control when it is found, I mean they could byv making ava6k worse, just dumping doxy everywhere, but why would they.

Pharma3's comments have been dissected earlier, and again are equally whiny.

So be magnanimous in your distribution of comments that people aren't adding to the discussion, as many threads are started with that sole intention by the looks of it.

I know who I'm waiting to see, let's see if they turn up.

Surely there is a path where 1 person shows signs so they have to add 3 more in to confirm? But if more than 1 had shown signs then we'd likely know by now, depending on when it occurred.

Short term LFTs, plural, are revenue, existing revenue streams to be expanded on.

Biosearch

They allowed to talk about other things whilst some of the team work with patients are having doses administered.

Not found yet. They are getting on with it, and it either might have been found, and they are confirming with more people, or there are no signs and there will be a Cohort 7 at which point there will be a MTD or something determined to use instead.

Surely this is all obvious? It's basic comprehension.

What about the MTD?

C2H...

https://avacta.com/wp-content/uploads/2023/06/Avacta-AGM-2023-presentations.pdf

Page 26 will give you some of the numbers you're looking for.

I wish he'd been around for 4D and DVRG, or that I'd listened to myself properly.

That's the long and the short of it, dox only released where needed instead of acting against whatever it comes across. So much greater concentrations where needed Vs std dox.

Where the fapa is, so outside, just like dox floating in the blood stream would arrive.

Livedataacccount, no.

It's going to taken up exactly the same as dox injected into the site works be taken up, because it is dox, it's not like dox, similar to dox or identical to dox, it is dox, and it will do what dox does which from what I can tell, based on the wounds it causes when there are injection issues, is kill cells.

It's not even that it's incomplete, the purpose of this phase is to answer the question 'does it kill you quicker than your cancer does' the cancer's shouldn't be susceptible to doxy. So zero shrinkage but no 'death by chemo' world be a great result, which we can prove already. The question is how much can we use as we are already at dosages that would be effective if the cancer was susceptible to doxy.

Here's the kicker though, we are at high enough levels that doxy might be having a beneficial effect where it is not expected to, it at least where it is not the normal treatment.

So the data you are asking for is not the point of this trial.

Ok my bad, didn't spot /kg Vs /m2 I'd still argue it's very very common to dose animals to many multiples of human doses.

So who is feeding whomever originally declared that they were unequal?